Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 599K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Arai, F. Articles by Suda, T. Search for Related Content PubMed PubMed Citation Articles by Arai, F. Articles by Suda, T. Social Bookmarking                            What's this?

Original Article

Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor b (Rank) Receptors

^a Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
^b Department of Periodontology, Meikai University School of Dentistry, Sakado 350-0248, Japan
^c Basic Research Laboratories, Toray Industries, Incorporated, Kamakura 248-0036, Japan
^d Department of Molecular Biology, Immunex Corporation, Seattle, Washington 98101-2936
Dept. of Cell Differentiation, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University School of Medicine, 2-2-1 Honjo, Kumamoto 860-0811, Japan.81-96-373-533281-96-373-5328

sudato{at}gpo.kumamoto-u.ac.jp

Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells. However, how their precursor cells diverge from macrophagic lineages is not known. We have identified early and late stages of osteoclastogenesis, in which precursor cells sequentially express c-Fms followed by receptor activator of nuclear factor B (RANK), and have demonstrated that RANK expression in early-stage of precursor cells (c-Fms⁺RANK^–) was stimulated by macrophage colony-stimulating factor (M-CSF). Although M-CSF and RANKL (ligand) induced commitment of late-stage precursor cells (c-Fms⁺RANK⁺) into osteoclasts, even late-stage precursors have the potential to differentiate into macrophages without RANKL. Pretreatment of precursors with M-CSF and delayed addition of RANKL showed that timing of RANK expression and subsequent binding of RANKL are critical for osteoclastogenesis. Thus, the RANK–RANKL system determines the osteoclast differentiation of bipotential precursors in the default pathway of macrophagic differentiation.

Key Words: osteoclastogenesis • commitment • macrophage • RANK ligand • M-CSF

Abbreviations used in this paper: BM, bone marrow; Dex, dexamethasone; Epo, erythropoietin; L, ligand; MNCs, multinucleated cells; NF, nuclear factor; OPG, osteoprotegerin; RANK, receptor activator of nuclear factor B; RT, reverse transcriptase; s, soluble; SCF, stem cell factor; TRAFs, TNFR-associated factors; TRAP, tartrate-resistant acid phosphatase.

© 1999 The Rockefeller University Press

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Vandyke, K., Fitter, S., Dewar, A. L., Hughes, T. P., Zannettino, A. C. W. (2010). Dysregulation of bone remodeling by imatinib mesylate. Blood 115: 766-774 [Abstract] [Full Text]  
• Nagase, Y., Iwasawa, M., Akiyama, T., Kadono, Y., Nakamura, M., Oshima, Y., Yasui, T., Matsumoto, T., Hirose, J., Nakamura, H., Miyamoto, T., Bouillet, P., Nakamura, K., Tanaka, S. (2009). Anti-apoptotic Molecule Bcl-2 Regulates the Differentiation, Activation, and Survival of Both Osteoblasts and Osteoclasts. J. Biol. Chem. 284: 36659-36669 [Abstract] [Full Text]  
• Ji, J.-D., Park-Min, K.-H., Shen, Z., Fajardo, R. J., Goldring, S. R., McHugh, K. P., Ivashkiv, L. B. (2009). Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN-{gamma} in Human Osteoclast Precursors. J. Immunol. 183: 7223-7233 [Abstract] [Full Text]  
• Lee, Y., Ha, J., Kim, H. J., Kim, Y.-S., Chang, E.-J., Song, W.-J., Kim, H.-H. (2009). Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis. J. Biol. Chem. 284: 33343-33351 [Abstract] [Full Text]  
• Ota, N., Takaishi, H., Kosaki, N., Takito, J., Yoda, M., Tohmonda, T., Kimura, T., Okada, Y., Yasuda, H., Kawaguchi, H., Matsumoto, M., Chiba, K., Ikegami, H., Toyama, Y. (2009). Accelerated Cartilage Resorption by Chondroclasts during Bone Fracture Healing in Osteoprotegerin-Deficient Mice. Endocrinology 150: 4823-4834 [Abstract] [Full Text]  
• Jansen, I. D. C., Mardones, P., Lecanda, F., de Vries, T. J., Recalde, S., Hoeben, K. A., Schoenmaker, T., Ravesloot, J.-H., van Borren, M. M. G. J., van Eijden, T. M., Bronckers, A. L. J. J., Kellokumpu, S., Medina, J. F., Everts, V., Oude Elferink, R. P. J. (2009). Ae2a,b-Deficient mice exhibit osteopetrosis of long bones but not of calvaria. FASEB J. 23: 3470-3481 [Abstract] [Full Text]  
• Furukawa, M., Takaishi, H., Takito, J., Yoda, M., Sakai, S., Hikata, T., Hakozaki, A., Uchikawa, S., Matsumoto, M., Chiba, K., Kimura, T., Okada, Y., Matsuo, K., Yoshida, H., Toyama, Y. (2009). IL-27 Abrogates Receptor Activator of NF-{kappa}B Ligand-Mediated Osteoclastogenesis of Human Granulocyte-Macrophage Colony-Forming Unit Cells through STAT1-Dependent Inhibition of c-Fos. J. Immunol. 183: 2397-2406 [Abstract] [Full Text]  
• Park-Min, K.-H., Ji, J.-D., Antoniv, T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M., Ivashkiv, L. B. (2009). IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-{kappa}B Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression. J. Immunol. 183: 2444-2455 [Abstract] [Full Text]  
• de Vries, T. J., Schoenmaker, T., Hooibrink, B., Leenen, P. J. M., Everts, V. (2009). Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J. Leukoc. Biol. 85: 919-927 [Abstract] [Full Text]  
• Sugatani, T., Hruska, K. A. (2009). Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function. J. Biol. Chem. 284: 4667-4678 [Abstract] [Full Text]  
• Chang, E.-J., Ha, J., Huang, H., Kim, H. J., Woo, J. H., Lee, Y., Lee, Z. H., Kim, J. H., Kim, H.-H. (2008). The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 121: 2555-2564 [Abstract] [Full Text]  
• Lorenzo, J., Horowitz, M., Choi, Y. (2008). Osteoimmunology: Interactions of the Bone and Immune System. Endocr. Rev. 29: 403-440 [Abstract] [Full Text]  
• Wise, G.E., King, G.J. (2008). Mechanisms of Tooth Eruption and Orthodontic Tooth Movement. JDR 87: 414-434 [Abstract] [Full Text]  
• Yao, Z., Xing, L., Qin, C., Schwarz, E. M., Boyce, B. F. (2008). Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine Mechanism. J. Biol. Chem. 283: 9917-9924 [Abstract] [Full Text]  
• Liu, W.-C., Chuang, W.-L., Tsai, M.-L., Hong, J.-H., McBride, W. H., Chiang, C.-S. (2008). Cordyceps sinensis Health Supplement Enhances Recovery from Taxol-Induced Leukopenia. Exp Biol Med 233: 447-455 [Abstract] [Full Text]  
• Kearns, A. E., Khosla, S., Kostenuik, P. J. (2008). Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease. Endocr. Rev. 29: 155-192 [Abstract] [Full Text]  
• Lee, Y., Hyung, S.-W., Jung, H. J., Kim, H.-J., Staerk, J., Constantinescu, S. N., Chang, E.-J., Lee, Z. H., Lee, S.-W., Kim, H.-H. (2008). The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon- induced inhibitory signaling. Blood 111: 885-893 [Abstract] [Full Text]  
• Cui, W., Cuartas, E., Ke, J., Zhang, Q., Einarsson, H. B., Sedgwick, J. D., Li, J., Vignery, A. (2007). CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts. Proc. Natl. Acad. Sci. USA 104: 14436-14441 [Abstract] [Full Text]  
• Niki, Y., Takaishi, H., Takito, J., Miyamoto, T., Kosaki, N., Matsumoto, H., Toyama, Y., Tada, N. (2007). Administration of Cyclooxygenase-2 Inhibitor Reduces Joint Inflammation but Exacerbates Osteopenia in IL-1{alpha} Transgenic Mice Due to GM-CSF Overproduction. J. Immunol. 179: 639-646 [Abstract] [Full Text]  
• Gonzalez-Suarez, E., Branstetter, D., Armstrong, A., Dinh, H., Blumberg, H., Dougall, W. C. (2007). RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini. Mol. Cell. Biol. 27: 1442-1454 [Abstract] [Full Text]  
• Mochizuki, A., Takami, M., Kawawa, T., Suzumoto, R., Sasaki, T., Shiba, A., Tsukasaki, H., Zhao, B., Yasuhara, R., Suzawa, T., Miyamoto, Y., Choi, Y., Kamijo, R. (2006). Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand. J. Immunol. 177: 4360-4368 [Abstract] [Full Text]  
• Dewar, A. L., Farrugia, A. N., Condina, M. R., Bik To, L., Hughes, T. P., Vernon-Roberts, B., Zannettino, A. C. W. (2006). Imatinib as a potential antiresorptive therapy for bone disease. Blood 107: 4334-4337 [Abstract] [Full Text]  
• Yao, Z., Li, P., Zhang, Q., Schwarz, E. M., Keng, P., Arbini, A., Boyce, B. F., Xing, L. (2006). Tumor Necrosis Factor-{alpha} Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression. J. Biol. Chem. 281: 11846-11855 [Abstract] [Full Text]  
• Lee, J., Kim, K., Kim, J. H., Jin, H. M., Choi, H. K., Lee, S.-H., Kook, H., Kim, K. K., Yokota, Y., Lee, S. Y., Choi, Y., Kim, N. (2006). Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693 [Abstract] [Full Text]  
• Nardelli, B., Zaritskaya, L., McAuliffe, W., Ni, Y., Lincoln, C., Cho, Y. H., Birse, C. E., Halpern, W., Ullrich, S., Moore, P. A. (2006). Osteostat/Tumor Necrosis Factor Superfamily 18 Inhibits Osteoclastogenesis and Is Selectively Expressed by Vascular Endothelial Cells. Endocrinology 147: 70-78 [Abstract] [Full Text]  
• Rogers, A., Eastell, R. (2005). Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor {kappa}B Ligand: Clinical Utility in Metabolic Bone Disease Assessment. J. Clin. Endocrinol. Metab. 90: 6323-6331 [Abstract] [Full Text]  
• Oka, S., Kubota, Y., Yamashiro, T., Ogata, S., Ninomiya, T., Ito, S., Shirasuna, K. (2005). Effects of Positive Pressure in Odontogenic Keratocysts. JDR 84: 913-918 [Abstract] [Full Text]  
• Wise, G.E., Yao, S., Odgren, P.R., Pan, F. (2005). CSF-1 Regulation of Osteoclastogenesis for Tooth Eruption. JDR 84: 837-841 [Abstract] [Full Text]  
• Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., Suda, T. (2005). DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. JEM 202: 345-351 [Abstract] [Full Text]  
• Horowitz, M. C., Xi, Y., Pflugh, D. L., Hesslein, D. G. T., Schatz, D. G., Lorenzo, J. A., Bothwell, A. L. M. (2004). Pax5-Deficient Mice Exhibit Early Onset Osteopenia with Increased Osteoclast Progenitors. J. Immunol. 173: 6583-6591 [Abstract] [Full Text]  
• Colucci, S., Brunetti, G., Rizzi, R., Zonno, A., Mori, G., Colaianni, G., Del Prete, D., Faccio, R., Liso, A., Capalbo, S., Liso, V., Zallone, A., Grano, M. (2004). T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. Blood 104: 3722-3730 [Abstract] [Full Text]  
• Hayashi, S.-I., Tsuneto, M., Yamada, T., Nose, M., Yoshino, M., Shultz, L. D., Yamazaki, H. (2004). Lipopolysaccharide-Induced Osteoclastogenesis in Src Homology 2-Domain Phosphatase-1-Deficient Viable Motheaten Mice. Endocrinology 145: 2721-2729 [Abstract] [Full Text]  
• Henriksen, K., Karsdal, M., Delaisse, J.-M., Engsig, M. T. (2003). RANKL and Vascular Endothelial Growth Factor (VEGF) Induce Osteoclast Chemotaxis through an ERK1/2-dependent Mechanism. J. Biol. Chem. 278: 48745-48753 [Abstract] [Full Text]  
• Hayashi, S.-I., Yamada, T., Tsuneto, M., Yamane, T., Takahashi, M., Shultz, L. D., Yamazaki, H. (2003). Distinct Osteoclast Precursors in the Bone Marrow and Extramedullary Organs Characterized by Responsiveness to Toll-Like Receptor Ligands and TNF-{alpha}. J. Immunol. 171: 5130-5139 [Abstract] [Full Text]  
• Kuwana, M., Okazaki, Y., Kodama, H., Izumi, K., Yasuoka, H., Ogawa, Y., Kawakami, Y., Ikeda, Y. (2003). Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol. 74: 833-845 [Abstract] [Full Text]  
• Moreno, J. L., Kaczmarek, M., Keegan, A. D., Tondravi, M. (2003). IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 102: 1078-1086 [Abstract] [Full Text]  
• Khapli, S. M., Mangashetti, L. S., Yogesha, S. D., Wani, M. R. (2003). IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage. J. Immunol. 171: 142-151 [Abstract] [Full Text]  
• Fox, S. W., Haque, S. J., Lovibond, A. C., Chambers, T. J. (2003). The Possible Role of TGF-{beta}-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro. J. Immunol. 170: 3679-3687 [Abstract] [Full Text]  
• Spessotto, P., Rossi, F. M., Degan, M., Di Francia, R., Perris, R., Colombatti, A., Gattei, V. (2002). Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. JCB 158: 1133-1144 [Abstract] [Full Text]  
• Ishida, A., Fujita, N., Kitazawa, R., Tsuruo, T. (2002). Transforming Growth Factor-beta Induces Expression of Receptor Activator of NF-kappa B Ligand in Vascular Endothelial Cells Derived from Bone. J. Biol. Chem. 277: 26217-26224 [Abstract] [Full Text]  
• Arai, F., Ohneda, O., Miyamoto, T., Zhang, X. Q., Suda, T. (2002). Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow Formation. JEM 195: 1549-1563 [Abstract] [Full Text]  
• Cappellen, D., Luong-Nguyen, N.-H., Bongiovanni, S., Grenet, O., Wanke, C., Susa, M. (2002). Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFkappa B. J. Biol. Chem. 277: 21971-21982 [Abstract] [Full Text]  
• Boissy, P., Saltel, F., Bouniol, C., Jurdic, P., Machuca-Gayet, I. (2002). Transcriptional Activity of Nuclei in Multinucleated Osteoclasts and Its Modulation by Calcitonin. Endocrinology 143: 1913-1921 [Abstract] [Full Text]  
• Nosaka, K., Miyamoto, T., Sakai, T., Mitsuya, H., Suda, T., Matsuoka, M. (2002). Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappa B ligand on adult T-cell leukemia cells. Blood 99: 634-640 [Abstract] [Full Text]  
• Lean, J. M., Fuller, K., Chambers, T. J. (2001). FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. Blood 98: 2707-2713 [Abstract] [Full Text]  
• Miyamoto, T., Ohneda, O., Arai, F., Iwamoto, K., Okada, S., Takagi, K., Anderson, D. M., Suda, T. (2001). Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554 [Abstract] [Full Text]  
• Fan, X., Fan, D., Gewant, H., Royce, C. L., Nanes, M. S., Rubin, J. (2001). Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells. Am. J. Physiol. Endocrinol. Metab. 280: E103-E111 [Abstract] [Full Text]  
• Miyamoto, T., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., Suda, T. (2000). An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood 96: 4335-4343 [Abstract] [Full Text]  
• Matsumoto, M., Sudo, T., Saito, T., Osada, H., Tsujimoto, M. (2000). Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-kappa B Ligand (RANKL). J. Biol. Chem. 275: 31155-31161 [Abstract] [Full Text]  
• Matsumoto, M., Hisatake, K., Nogi, Y., Tsujimoto, M. (2001). Regulation of Receptor Activator of NF-kappa B Ligand-induced Tartrate-resistant Acid Phosphatase Gene Expression by PU.1-interacting Protein/Interferon Regulatory Factor-4. SYNERGISM WITH MICROPHTHALMIA TRANSCRIPTION FACTOR. J. Biol. Chem. 276: 33086-33092 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS